SCHEMBL14082153

SCHEMBL14082153

CN1CCC(NC(=O)c2ccc(-c3ncccc3Cl)cc2)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIM1 P11309 1/20 0.52
▸ PIM3 Q86V86 1/20 0.52
▸ PIM2 Q9P1W9 1/20 0.52
▸ TRPV1 Q8NER1 3/20 0.52
▸ SSTR4 P31391 1/20 0.52
▸ HDAC4 P56524 1/20 0.50
▸ HDAC6 Q9UBN7 1/20 0.50
▸ JAK1 P23458 1/20 0.49
▸ TRPV4 Q9HBA0 1/20 0.48
▸ ATR Q13535 1/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ MEN1 O00255 1/20 0.48
▸ AURKA O14965 2/20 0.48
▸ AURKB Q96GD4 2/20 0.48
▸ ROCK2 O75116 1/20 0.48
▸ RIPK1 Q13546 1/20 0.47
▸ WDR5 P61964 1/20 0.47
▸ GABRA5 P31644 1/20 0.46
▸ POLB P06746 1/20 0.46
▸ SLC6A5 Q9Y345 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14082150 0.89 MEN1 (0.56) TRPV1TRPV4KMT2AMEN1RIPK1
SCHEMBL14082149 0.87 TRPV1 (0.54) TRPV1KMT2AMEN1RIPK1
SCHEMBL14082136 0.86 TRPV1 (0.53) TRPV1KMT2AMEN1RIPK1
SCHEMBL28683091 0.84 JAK3 (0.50) PIM1PIM3PIM2HDAC4HDAC6
SCHEMBL30108270 0.84 JAK3 (0.50) PIM1PIM3PIM2HDAC4HDAC6
SCHEMBL14082141 0.84 TMEM97 (0.63) KMT2AMEN1POLB
SCHEMBL4591089 0.83 TRPV1 (0.56) TRPV1TRPV4KMT2AMEN1RIPK1
SCHEMBL4590988 0.83 TRPV1 (0.56) TRPV1TRPV4KMT2AMEN1RIPK1
SCHEMBL4590899 0.83 TRPV1 (0.56) TRPV1TRPV4KMT2AMEN1RIPK1
SCHEMBL14082791 0.83 NTRK1 (0.51) SSTR4KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof TRPV1, TRPA1, TRPV2 PIM1 4501/4885PIM3 4437/4885PIM2 4285/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback